Introduction
Natural compounds with more than one indole skeleton have been reported to show anticancer activity by interacting with different cellular targets.
1−8 The 3,3 ′ -bisindole oxindole and 3-substituted oxindole skeleton belongs to a class of privileged heterocyclic frameworks, which constitutes the core structures of many bioactive compounds ( Figure 1 ). Additionally, 2-alkylindoles and 2.2 ′ -bis(indolyl)methanes represent quite an interesting class and are also known to play an important role in numerous biological and technological processes.
9−12
Therefore, a great deal of attention has been given to the development of effective, facile, and innovative synthetic strategies for the enhancement of indole chemistry. Indole is an electron-rich heteroaromatic system, and although various methods for synthesis of C3-substituted derivatives are well known, the synthesis of C2-substituted derivatives continues to be a difficult task. 13−24 While a number of methods have already been published for the synthesis of 3-substituted indole derivatives, there are no methods for the synthesis of 2-substituted indole derivatives through the indole ring. An alternative method that utilizes 4,7-dihydro-1 H -indole (2) derivatives as synthetic equivalents (synthons) for easy synthesis of 2-substituted indoles was developed by Saraçoglu and coworkers 25−28 ( Figure 2 ). The indole (1) exhibits reactivity at the C-3 position against the electrophiles and forms the 3-substituent indole derivatives at the end of the reaction. The advantage of this strategy developed by Saraçoglu and coworkers is that the derivatives 2 and 3 obtained as a result of * Correspondence: snanbay@atauni.edu.tr reduction of the indole (1) are also pyrrole derivatives. The obtained molecules 2 and 3 electrophilically react with C-2 carbon to give 2-substituted indole derivatives ( Figure 2 ). The technological applications of synthetic indole derivatives have attracted a great deal of interest in recent years. 29−31 In this context, the indole skeleton is a highly used unit for biological chemosensor applications. Previous studies of bisindole derivatives revealed that they alter the enzymatic activity of some enzymes like human carbonic anhydrase isoforms I-II and α /β -glycosidase. In a recent study, the antioxidant activities of 1,4-bis(indolin-1-ylmethyl)benzene derivatives were reported by Talaz and coworkers. 32 However, there is no study investigating the effect of such compounds on metabolic enzymes including glucose-6-phosphate dehydrogenase (G6PD; E.C.1.1.1.49) and 6-phosphogluconate dehydrogenase (6PGD; E.C.1.1.1.44). Therefore, one aim of the work described in this paper is to investigate the effect of indole derivatives on the activity of the corresponding enzymes. G6PD is the rate-limiting enzyme of the pentose phosphate pathway. It catalyzes the irreversible conversion of glucose 6-phosphate to 6-phosphoglucono-δ -lactone in the presence of NADP + .
33
6PGD is the third enzyme in the pentose phosphate pathway. It is a well-known oxidative carboxylase that catalyzes conversion of 6-phosphogluconate into ribulose 5-phosphate. 34 The pentose phosphate pathway is one of the key components of cellular metabolism. It is strongly connected to glycolysis as a major consumer of glucose. The primary roles of the pathway are generating NADPH as a source of reducing power and the synthesis of ribose 5-phosphate, which is required for the synthesis of nucleic acids. 35, 36 In the absence of these enzymes the erythrocyte is susceptible to oxidative damage. G6PD is also associated with some human diseases including cancer, metabolic disorders, and cardiovascular diseases. 37−39 It was also reported that suppression of 6PGD decreased lipogenesis and RNA biosynthesis and increased reactive oxygen levels in cancer cells, lessening cell proliferation and tumor growth and suggesting that 6PGD could be an anticancer target.
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In our previous studies, we developed an efficient, facile, and atom-economical protocol for the preparation of 2-alkylated indoles and bis(2-indolyl)methanes derivatives through addition of one or two equivalents of 4,7-dihydro-1H -indole (2) using ketones as electrophiles followed by an oxidation step 28 (Scheme 1a). Herein,
Bi(NO 3 )
.
3 5H 2 O-catalyzed reactions of 4,7-dihydro-1H -indole (2) with isatin (4) (Scheme 1b) and the obtained molecules were examined along with investigating their effects on the enzymatic activity of rat erythrocyte G6PD and 6PGD and docking studies. 
Results and discussion

Chemistry
Our research interest in the synthesis of new oxindole derivatives with 1,2-and 1,3-diketones of 4,7-dihydro-1H -indole (2) encouraged us to ascertain the behavior of ketones having a different nature against the condensation reactions of 4,7-dihydro-1H -indole (2) . In this context, initially 4,7-dihydro-1H -indole, which was used as an output molecule in the reactions, was synthesized via Birch reduction reaction of indole with Li in liquid ammonia. The Birch reduction, a very powerful reducing system, has been reported to yield a mixture of 4,7-dihydro-1H -indole (2) and 4,5,6,7-tetrahydroindole (3) in a 4:1 ratio according to NMR, which could be best separated by recrystallization or distillation.
25−28 Isatin (4) as an 1,2-diketone derivative has provided an opportunity to investigate the effect of the carbonyl group on the condensation of 4,7-dihydro-1H -indole (2) with ketone (Scheme 2). As shown in Table 1 , the reaction of 4,7-dihydro-1H -indole with isatin (4) Surprisingly, the oxidation of alcohol derivative 5 with MnO 2 produced unexpected amine derivative (2-aminophenyl)(1H -indol-2-yl)methanone (7) in 81% yield instead of the expected product 8 (Schemes 2 and 3). The same results were obtained with p -benzoquinone (p BQ) or DDQ (2,3-dichloro-5,6-dicyano-1,4-benzoquinone) in 25% and 12% yields, respectively. It was seen that one NH group resonated at 9.29 ppm in the 1 H NMR spectrum of unexpected amine derivative 7. The two protons available in amine units resonated at 5.71 ppm. Also, while the 13 C NMR resonance signal was available at 177.0 ppm in the 13 C NMR spectrum of unexpected amine derivative 7, the signal shows the existence of a ketone group in the molecule and 14 carbon resonance signals in the aromatic area, supporting the recommended structure (Scheme 2). Because of the sensitivity of the carbonyl group toward moisture the hydration of the carbonyl group undergoes carbon/nitrogen bond cleavage to give unexpected amine derivative 7 and carbon dioxide (Scheme 3).
Bis/tris-indole derivatives are an important class of biological active indoles. In this context, the reaction of 2 equivalents of 4,7-dihydro-1H -indole (2) with one equivalent of isatin (4) was also performed under similar conditions (Scheme 4). The 2,2 ′ -bis(indolyl)oxindole (12) , which resembles anticancer agent 3,3 ′ -bis(indolyl)oxindole, was synthesized by condensation of 4,7-dihydro-1H -indole (2, 2 equiv.) with isatin (4, 1 .
3 5H 2 O in CH 3 CN, followed by an oxidation reaction by p -benzoquinone over 4,7-dihydro-1H -indole derivative 11 (Scheme 4). Despite all attempts, 4,7-dihydro-1H-indole derivative 11, which was seen from NMR spectra, could not be isolated.
Additionally, the reactions of 4,7-dihydro-1H -indole (2) with other 1,2-and 1,3-diketones such as 2,3-butanedione (13), acenaphthoquinone (14) , and cyclohexane-1,3-dione (15) were examined under the same conditions ( Figure 3 ). No significant results were obtained from the studies of 1,2-diketones. While the reaction of diketones 13 and 14 gave no isolable product, no reaction was observed with cyclohexane-1,3-dione (15). 
G6PD and 6PGD inhibition/activations studies
Following synthesis of the bisindole derivatives 5, 7, and 12, investigation of the effects of these derivatives on rat blood erythrocyte G6PD and 6PGD was conducted. In order to achieve that, first G6PD and 6PGD were purified from rat blood erythrocytes by 2 ′ ,5 ′ -ADP Sepharose 4B affinity chromatography. 41−43 Following purification, the in vitro effects of ligands 5, 7, and 12 on the activity of both enzymes were investigated. The inhibition effect of the compounds on enzymes is expressed in IC 50 values and K i constants. Derivatives 5, 7, and 12 inhibited the activity of G6PD with an IC 50 of 99 µ M, 231 µ M, and 304 µ M, respectively (Table 2 , Figure S8 , ESI). To further understand the mechanism by which these compounds inhibited these enzymes, the inhibitory modes of the derivatives were studied. The collected raw data were described as Lineweaver-Burk diagrams and suggested that all derivatives except 5 inhibited the activity of G6PD noncompetitively with respect to G6P as the reaction rate was decreased and K m remained unchanged while 5 was a competitive inhibitor of G6PD. Their K i values were calculated based on this diagram to be 48 µ M, 369 µ M, and 304 µ M respectively ( Figure S9 , ESI). As suggested by the IC 50 and K i values of each compound, inhibition is most powerful by ligand 5. This could be attributed to the hydrogen bonding capacity of the compounds with the amino acid residues of the enzyme. Indole derivative 5 has three groups that can make hydrogen bonds and it also has oxygen, which is more electronegative than other atoms, which makes it form stronger hydrogen bonds with the amine group of the amino acid residues. These properties may make indole derivative 5 a more powerful inhibitor than the others. 
The effects of these compounds on 6PGD were also tested. Unlike G6PD, the activity of 6PGD was increased approximately fourfold (380%) in the presence of 250 µ M indole derivative 5 and the activity was increased approximately twofold (176%) in the presence of 1500 µ M indole derivative 7. However, activity was inhibited in the presence of indole derivative 12 with an IC 50 of 209 µM (Table 2, Figure S10 , ESI).
Molecular docking analysis
The inhibition studies revealed that compound 5 inhibited the activity of G6PD competitively. To elucidate the binding modes of 5 in rat erythrocyte G6PD, a homology model of the structure of the enzyme was generated and ligand 5 was docked. In contrast to its effect on G6PD, the presence of the ligand increased the activity of 6PGD. To further understand the effect, the structure of the enzyme was generated by homology modeling and docking studies were performed. The results of docking studies were analyzed manually (Figures 5a-5d and S11, ESI). It was revealed that the ligand was located close to the substrate and ligand binding site without interacting with any residues around it. It was postulated that the ligand could assist in increasing the activity of the enzyme by reducing NADP + to NADPH. In catalysis, two residues, one acting as an acid (Glu) and the other as a base (Lys), are proposed to contribute to all three catalytic steps of the reaction catalyzed by 6PGD: dehydrogenation, decarboxylation, and keto-enol tautomerization. Lys is thought to be unprotonated in the enzyme/substrate complex, where it takes a proton from the 3-OH of 6PGA as a hydride that is transferred from the C3 of 6PGA to NADP + . The resultant 3-keto-6PGA intermediate is subsequently decarboxylated to 
44−47
As shown in Figures 5a-5d and Scheme 5, it is proposed that NADP + will assist in converting 6PGA to R5P. Following that, it will oxidize the 4,7-dihydro indole unit in ligand 5 to an indole unit. The amino group of an arginine residue located in the close vicinity of 5 will behave as a base and attack the C 7 -H of 4,7-dihydro-1H -indole, forming an aromatic ring, which is then receiving protons from C 4 -H and reduces NADP + to NADPH, thus increasing the activity of the enzyme (Scheme 5).
In conclusion, we have reported the synthesis of possible biologically active new indoles 3-(4,7-dihydro-1 H -indol-2-yl)-3-hydroxyindolin-2-one (5), (2-aminophenyl)(1H -indol-2-yl)methanone (7), and 1 (12) from the reaction of 4,7-dihydro-1H -indole (2) with isatin (4) and have discussed the formation mechanism. In addition to synthesis, effects of indole derivatives 5, 7, and 12 on the activity of erythrocyte G6PD and 6PGD have also been investigated in in vitro conditions. These studies showed that 5, 7, and 12 inhibited the activity of G6PD with an IC50 of 99 µ M, 231 µ M, and 304 µM, respectively. However, studies on rat erythrocyte 6PGD indicated that the activity was increased in the presence of 5 and 
Experimental
All chemicals, reagents, and solvents were commercially available from Sigma-Aldrich or Merck and were used as received. Column chromatography was carried out on silica gel 60 (230-400 mesh ASTM). The reaction progress was monitored by thin-layer chromatography (TLC) (0.25-mm-thick precoated silica plates: Merck Fertigplatten Kieselgel (60 F254)). UV-Vis spectra were recorded on a Shimadzu UV-3101PL UV-Vis-NIR spectrometer.
Synthesis of 4,7-dihydro-1H-indole (2)
Compound 2 was prepared according to the literature method. 
The reaction of 4,7-dihydro-1H -indole (2, 1 equiv.) with isatin (4, 1 equiv.)
To a solution of 4,7-dihydro-1H -indole (2, 200 mg, 1.68 mmol) in MeCN (5 mL), indoline-2,3-dione (4, isatin, 247 mg, 1.68 mmol) and Bi(NO 3 )
. 3 5H 2 O (0.1 mmol) were added. The reaction mixture was stirred magnetically in a flask at 100
• C. The reaction was monitored by TLC. After the completion of the reaction, the mixture was diluted with ethyl acetate (30 mL) and washed with water (2 × 50 mL), and the organic phase was dried over Na 2 SO 4 . The crude product was purified by silica gel column chromatography and the isolated compound was given according to the elution sequence (EtOAc/Hexane; v/v: 1/3). After purification, 3-(4,7-dihydro- 
The oxidation of 3-(4,7-dihydro-1H -indol-2-yl)-3-hydroxy indolin-2-one (5)
Procedure A: To a solution of 3-(4,7-dihydro-1H -indol-2-yl)-3-hydroxyindolin-2-one (5, 300 mg, 1.13 mmol) in 10 mL of CH 2 Cl 2 was added MnO 2 (980 mg, 11.3 mmol). After stirring for 12 h at room temperature, the mixture was diluted with EtOAc (30 mL) and washed with water (3 × 30 mL), and the organic phase was dried over Na 2 SO 4 . The crude product (230 mg) was eluted on silica gel (25 g) with EtOAc/hexane (v/v: 3/7).
After purification, (2-aminophenyl)(1H -indol-2-yl)methanone (7, 215 mg, 81%) was obtained as a white solid (mp: 115-116 • C (crystallized over CH 2 Cl 2 / hexane)).
Procedure B: (2-Aminophenyl)(1H -indol-2-yl)methanone (7) was obtained as a white solid (67 mg, 25%) from the reaction of 3-(4,7-dihydro-1H -indol-2-yl)-3-hydroxyindolin-2-one (5, 300 mg, 1.13 mmol) with p -benzoquinone (304 mg, 2.82 mmol) in CH 2 Cl 2 at room temperature for 12 h.
Procedure C: (2-Aminophenyl)(1H-indol-2-yl)methanone (7) 
The reaction of 4,7-dihydro-1H -indole (2, 2 equiv.) with isatin (4, 1 equiv.)
To a solution of 4,7-dihydro-1H -indole (2; 300 mg, 2.50 mmol) in MeCN (5 mL) was added isatin (4, 185 mg,
mmol) and Bi(NO 3 )
. 3 5H 2 O (0.1 mmol). The reaction mixture was stirred magnetically in a flask at 100
The reaction was monitored by TLC. After the completion of the reaction, the mixture was diluted with ethyl acetate (30 mL) and washed with water (2 × 50 mL), and the organic phase was dried over Na 2 SO 4 . The crude product was dissolved in CH 2 Cl 2 (15 mL) and p -benzoquinone (330 mg, 3.06 mmol) was added. The mixture was stirred at room temperature overnight. After completion of the reaction, the solvent was evaporated, the crude product was dissolved with ethyl acetate (30 mL), and the organic phase was washed with NaOH (2 N, 2 × 30 mL) and brine (30 mL) and dried over Na 2 SO 4 . The crude product was purified by silica gel column chromatography and isolated compounds was given according to elution sequence (EtOAc/hexane; v/v: 3/17). 
Preparation of hemolysate
Fresh blood samples were obtained from rats and placed in EDTA-containing tubes. In order to distinguish erythrocytes from plasma, blood samples were filtered to remove any impurities, then centrifuged for 15 min at 2500 × g to remove plasma. After that the precipitated erythrocytes were washed three times with 0.16 M KCl and hemolyzed with 5 volumes of cold water. Then, to remove the cell membranes and intact cells, 30 min of centrifugation at 10,000 × g was performed. 
In vitro enzyme inhibition studies
G6PD and 6PGD enzyme activities were measured at 25
• C spectrometrically at 340 nm by following the rate of appearance of NADPH. Assays were initiated by the addition of enzyme to 1.0 mL of 100 mM Tris-HCl, pH 8, containing 0.5 mM EDTA, 0.01 mM MgCl 2 , 0.6 mM G6P/6PGA, and 0.2 mM NADP + . To determine the effect of compounds 5, 7, and 12 on the activity of rat erythrocyte G6PD and 6PGD, different concentrations of the corresponding compounds were added in the assay mixture given above. The enzyme activities in the absence of compounds were taken as 100%. Activity % vs. compound concentration graphs were drawn and used to calculate the drug concentrations causing a 50% decrease in enzyme activity (IC 50 values). The types of inhibition and K i constants were determined via Lineweaver-Burk graphs.
Structure preparation, homology modeling, and ligand docking
The sequences of G6PD and 6PGD of rat erythrocytes were retrieved from UniProt (http://www.uniprot.org/ uniprot) in the FASTA format. The sequences were then submitted to PHYRE2 (Protein Homology/analogy Recognition Engine V 2.0) for protein structure prediction. 49 The X-ray crystal structures of human G6PD
(PDB-ID: 1QKI) and sheep 6PGD (PDB-ID: 1PGP) were used as starting structures for molecular modeling.
PROCHECK
48 was used for model validation. The molecular structure of compound 5 was built in Chem3D
Pro 12.0 and energy-minimized prior to docking studies. Ligand docking calculations were performed in SwissDock. 49 The docked structures were examined manually and the best pose for the inhibitor was selected on the basis of the DG value, the scaffold conformation, and the hydrogen bonds formed between residues and the inhibitor. Estimated DG values for each docking cluster are given in Table S1 . UCSF Chimera and PyMol were used for molecular visualization.
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1 Supporting Information Figure S1 . 1 H NMR (400 MHz) spectra of 3-(4,7-dihydro-1H-indol-2-yl)-3-hydroxyindolin-2-one (5) (DMSO-d6).
Figure S2.
13 C NMR (100 MHz) spectra of 3-(4,7-dihydro-1H-indol-2-yl)-3-hydroxyindolin-2-one (5) (DMSO-d6).
Figure S3.
1 H NMR (400 MHz) spectra of (2-aminophenyl)(1H-indol-2-yl)methanone (7) (CDCl 3 ).
Figure S4.
13 C NMR (100 MHz) spectra of (2-aminophenyl)(1H-indol-2-yl)methanone (7) (CDCl 3 ). 
